Caloric Restriction: What Human Studies Actually Show

Caloric restriction has one of the longest histories in ageing research. The idea is simple: consume fewer calories than usual while still obtaining enough protein, vitamins, minerals, and essential fats.

In short-lived laboratory animals, this can extend lifespan dramatically. That has encouraged a much bigger claim—that a healthy person could eat 20–30% less and gain decades of life.

Human research has not established that claim. Caloric restriction can reduce body weight and improve several metabolic risk markers, but no controlled human trial has shown that it extends maximum lifespan or adds a particular number of years.

What caloric restriction means

Researchers use caloric restriction to mean a sustained reduction in energy intake without malnutrition. It is different from:

• Fasting, which restricts when food is eaten.
• Weight-loss dieting, which is usually intended to reduce excess body fat.
• Starvation or crash dieting, which can produce nutrient deficiencies and substantial tissue loss.
• Eating a healthier diet, which can improve food quality without deliberately cutting calories.

Those approaches can overlap, but their effects cannot be assumed to be identical. A person may practice time-restricted eating without reducing calories, for example, while another person may reduce calories without fasting.

The animal evidence is strong—but not universal

Caloric restriction has extended lifespan in yeast, worms, flies, rodents, and some other laboratory animals. The size and even direction of the effect vary with species, strain, sex, diet composition, age at which restriction begins, and the amount of food eaten by the control group.

Results in rhesus monkeys illustrate the uncertainty. A University of Wisconsin study reported a survival benefit, while a US National Institute on Aging study did not find a significant lifespan extension. A later joint analysis concluded that both studies supported health benefits, but differences in feeding practices, diet, genetics, and starting age helped explain the different survival results (Mattison et al., 2017).

This matters because a finding in a mouse is not a scaled-down clinical instruction for a human. Humans live much longer, eat more varied diets, and face different risks from losing muscle and bone.

The best-known human experiment: CALERIE

The most informative randomized human study is the two-year CALERIE phase 2 trial. It enrolled 218 healthy adults aged approximately 21–50 whose BMI was in the normal or mildly overweight range. Participants were assigned either to continue eating as usual or to aim for a 25% calorie reduction.

The intervention group did not sustain the full 25%. Average restriction was closer to 12% over two years, accompanied by an average weight loss of about 7.5 kg.

Compared with the control group, participants assigned to caloric restriction improved several cardiometabolic risk factors, including blood pressure, cholesterol measures, insulin sensitivity, and inflammation. These are encouraging intermediate outcomes, but they are not proof of longer life. The study was too short and too small to measure effects on lifespan, heart attacks, cancer, or dementia.

A later analysis of stored blood samples examined three DNA-methylation measures of biological ageing. Two showed no significant change. One measure, DunedinPACE, suggested that the pace of ageing slowed by approximately 2–3% (Waziry et al., 2023). This was a small, post-hoc biomarker result—not evidence that participants will live 20 or 30% longer.

Benefits and trade-offs

For someone with excess body fat, a moderate energy deficit can improve health partly through weight loss. CALERIE is interesting because its participants did not have obesity and still experienced improvements in several markers.

There were trade-offs. Participants lost some lean tissue as well as fat, and bone-mineral density fell modestly at the hip and spine. The trial carefully screened participants and provided intensive support; people with low bone density, eating disorders, significant illness, or depression were excluded. Its safety findings therefore should not be generalized to everyone (Romashkan et al., 2016).

A systematic review of human randomized trials found improvements in weight, fat mass, total cholesterol, and some metabolic outcomes, but also small declines in lean mass and bone density. The trials were too short and limited to identify an ideal level of long-term restriction or prove prevention of chronic disease (Caristia et al., 2020).

Caloric restriction is not intermittent fasting

Fasting is often described as a convenient way to obtain the same longevity effects. That conclusion is premature.

Time-restricted eating or intermittent fasting may help some people reduce overall intake, but timing food does not guarantee a calorie deficit or a nutritionally adequate diet. Human trials usually measure weight and metabolic markers over months, not lifespan over decades.

If a fasting schedule helps someone avoid late-night snacking while maintaining good nutrition, it may be a useful behavioural tool. It should not be presented as a proven anti-ageing treatment independent of calorie intake, food quality, sleep, and activity.

Who should be especially cautious?

Deliberate caloric restriction may be inappropriate or require clinical supervision for:

• Children, adolescents, and people who are pregnant or breastfeeding.
• Anyone who is underweight, frail, or unintentionally losing weight.
• People with a current or previous eating disorder.
• Older adults at risk of sarcopenia, falls, or osteoporosis.
• People with diabetes or medication that can cause low blood glucose.
• Athletes and highly active people with substantial energy needs.
• Anyone recovering from surgery, infection, or another condition that raises nutritional requirements.

Signs such as persistent fatigue, feeling cold, dizziness, menstrual disruption, loss of strength, worsening mood, or preoccupation with food are reasons to stop and seek qualified advice.

A more defensible practical approach

The evidence does not justify telling healthy adults to cut calories by 30% for life. A safer longevity strategy is to avoid chronic overconsumption while protecting muscle, bone, and nutrient intake.

That usually means:

1. Build meals around vegetables, fruit, legumes, whole grains, nuts, and adequate protein.
2. Reduce foods and drinks that add substantial energy without much nutritional value.
3. Use resistance training and regular aerobic activity to protect function.
4. If weight loss is appropriate, aim for a moderate, sustainable deficit rather than maximum restriction.
5. Monitor strength and overall wellbeing, not just scale weight.
6. Get individualized advice when health conditions, medications, low body weight, or a history of disordered eating complicate the picture.

Resveratrol, fisetin, metformin, and rapamycin should not be described as substitutes for caloric restriction. Foods containing particular compounds are not equivalent to experimental drug doses, and prescription medicines have risks and specific clinical uses.

The bottom line

Caloric restriction reliably extends lifespan in some laboratory models and improves several health markers in short human trials. It has not been proved to extend human lifespan, and “eat 30% less to live 30% longer” is not a scientifically supported equation.

The most credible human result is modest: roughly 12% restriction for two years improved several cardiometabolic markers and produced a small change in one of three biological-ageing measures. Whether those changes translate into longer, healthier lives remains unknown.

For most people, maintaining a healthy body composition, eating a nutrient-rich diet, staying active, and preserving muscle are better-supported goals than pursuing severe lifelong restriction.

Sources

• Mattison et al.: Caloric restriction improves health and survival of rhesus monkeys
• CALERIE phase 2 trial registration
• Kraus et al.: Two years of calorie restriction and cardiometabolic risk
• Waziry et al.: Caloric restriction and DNA-methylation measures of ageing
• Romashkan et al.: Safety of two-year caloric restriction
• Villareal et al.: Caloric restriction and bone-mineral density
• Caristia et al.: Systematic review of caloric restriction and healthy ageing

Editorial note

This article was substantially rewritten on July 19, 2026. The earlier version treated animal lifespan findings as if they established equivalent gains in humans and has been withdrawn from publication.